Gary Goldenberg

Insider Reports History

Entity
Individual
Location
C/O Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester, PA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gary Goldenberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. Chief Medical Officer Common Stock 94.3K $232K $2.46 Aug 27, 2024 Direct
Verrica Pharmaceuticals Inc. Chief Medical Officer Employee Stock Option (right to buy) 80K Mar 15, 2024 Direct

Insider Reports Filed by Gary Goldenberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRCA Verrica Pharmaceuticals Inc. Aug 26, 2024 2 -$35.2K 4 Aug 28, 2024 Chief Medical Officer
VRCA Verrica Pharmaceuticals Inc. Jul 22, 2024 2 -$131K 4 Jul 23, 2024 Chief Medical Officer
VRCA Verrica Pharmaceuticals Inc. Mar 15, 2024 2 $0 4 Mar 19, 2024 CHIEF MEDICAL OFFICER
VRCA Verrica Pharmaceuticals Inc. Nov 14, 2023 2 -$26.1K 4 Nov 16, 2023 Chief Medical Officer
VRCA Verrica Pharmaceuticals Inc. Aug 24, 2023 1 $0 4 Aug 28, 2023 Chief Medical Officer
VRCA Verrica Pharmaceuticals Inc. Jul 21, 2023 2 -$139K 4 Jul 25, 2023 Chief Medical Officer
VRCA Verrica Pharmaceuticals Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Chief Medical Officer
VRCA Verrica Pharmaceuticals Inc. Jul 5, 2022 1 $50K 4 Jul 5, 2022 Chief Medical Officer
VRCA Verrica Pharmaceuticals Inc. Feb 24, 2022 1 $0 4 Feb 25, 2022 Chief Medical Officer